Liste des publications médicales 2017

Retrouvez ci-dessous la liste des ouvrages et des articles scientifiques publiés en 2017 par nos services.

Archives : 2016 | 20152014

Cardiologie

  • Stoller M, Gloekler S, Zbinden R, Tueller D, Eberli F, Windecker S, Wenaweser  P, Seiler C. Left Ventricular Afterload Reduction by Transcatheter Aortic ValveImplantation in Severe Aortic Stenosis and its Prompt Effects on Comprehensive Coronary Hemodynamics. EuroIntervention, 2017: in press.
  • Abraham P, Arroyo DA, Giraud R, Bounameaux H, Bendjelid K. Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper. Open Heart. 2017: in press.
  • Melly L, Cerino G, Frobert A, Cook S, Giraud MN, Carrel T, Tevaearai Stahel HT, Eckstein F, Rondelet B, Marsano A, Banfi A. Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth  Factor levels. J Cell Mol Med. 2017: in press.
  • Schoenenberger AW, Moser A, Bertschi D, Wenaweser P, Windecker S, Carrel T, Stuck AE, Stortecky S. Improvement of Risk Prediction After Transcatheter Aortic Valve Replacement by Combining Frailty With Conventional Risk Scores. JACC Cardiovasc Interv. 2017: in press.
  • Asami M, Stortecky S, Praz F, Lanz J, Räber L, Franzone A, Piccolo R, Siontis GCM, Heg D, Valgimigli M, Wenaweser P, Roost E, Windecker S, Pilgrim T.Prognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Imaging. 2017: in press.
  • Arroyo DA, Schukraft S, Kallinikou Z, Stauffer JC, Baeriswyl G, Goy JJ, Togni  M, Cook S, Puricel S. Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial. Open Heart. 2018 Jan 3;5(1):e000624. doi:10.1136/openhrt-2017-000624. 2017: in press.
  • Fournier S, Muller O, Benedetto U, Roffi M, Pilgrim T, Eberli FR, Rickli H,Radovanovic D, Erne P, Cook S, Noble S, Fesselet R, Zuffi A, Degrauwe S, Masci P,Windecker S, Eeckhout E, Iglesias JF; on behalf on the AMIS Plus Investigators.Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clin Res Cardiol. 2018 Apr;107(4):338-346. doi:10.1007/s00392-017-1189-8. Epub 2017 Dec 8. PubMed PMID: 29222592.
  • Pilgrim T, Franzone A, Stortecky S, Nietlispach F, Haynes AG, Tueller D,Toggweiler S, Muller O, Ferrari E, Noble S, Maisano F, Jeger R, Roffi M,Grünenfelder J, Huber C, Wenaweser P, Windecker S. Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model. Circ Cardiovasc Interv. 2017 Nov;10(11). pii: e005481. doi: 10.1161/CIRCINTERVENTIONS.117.005481. PubMed PMID: 29127116.
  • Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Carrié D, Hovasse T, Garot P, El Mahmoud R, Spaulding C, Helft G, Diaz Fernandez JF, Brugaletta S,Pinar-Bermudez E, Mauri Ferre J, Commeau P, Teiger E, Bogaerts K, Sabate M, Morice MC, Sinnaeve PR; SENIOR investigators. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet. 2017: in press.
  • Jain M, Frobert A, Valentin J, Cook S, Giraud MN. The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury. J Vis Exp. 2017 Oct 3;(128). doi: 10.3791/55295. PubMed PMID: 28994792.
  • Noble S, Cook S. Une alternative à l’anticoagulation chez le patient âgé ? Rev Med Suisse. 2017 Mar 1;13(552):529. French. PubMed PMID: 28714622.
  • Bleiziffer S, Bosmans J, Brecker S, Gerckens U, Wenaweser P, Tamburino C, Linke A; ADVANCE Study Investigators. Erratum to: Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study. Clin Res Cardiol. 2017 Oct;106(10):849. doi: 10.1007/s00392-017-1124-z. PubMed PMID: 28676951.
  • Cassese S, Byrne RA, Jüni P, Wykrzykowska JJ, Puricel S, Ndrepepa G, Schunkert H, Fusaro M, Cook S, Kimura T, Henriques JPS, Serruys PW, Windecker S, Kastrati A. Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials. EuroIntervention. 2017: in press.
  • Falk V, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Linke A, Ince H, Wenaweser P, Allocco DJ, Dawkins KD, Van Mieghem NM. Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study. Eur Heart J. 2017 Dec 1;38(45):3359-3366. doi: 10.1093/eurheartj/ehx297. PubMed PMID: 28651336.
  • Gerckens U, Tamburino C, Bleiziffer S, Bosmans J, Wenaweser P, Brecker S, Guo J, Linke A. Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. Eur Heart J. 2017 Sep 21;38(36):2729-2738. doi: 10.1093/eurheartj/ehx295.
    PubMed PMID: 28633375; PubMed Central PMCID: PMC5837353.
  • Jeger RV, Pfister O, Radovanovic D, Eberli FR, Rickli H, Urban P, Pedrazzini G, Stauffer JC, Nossen J, Erne P; AMIS-Plus Investigators. Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry. Clin Cardiol. 2017 Oct;40(10):907-913. doi: 10.1002/clc.22745. Epub 2017 Jun 9. PubMed PMID: 28598569.
  • Vlachojannis GJ, Smits PC, Hofma SH, Togni M, Vázquez N, Valdés M, Voudris V, Slagboom T, Goy JJ, den Heijer P, van der Ent M. Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent). JACC Cardiovasc Interv. 2017 Jun 26;10(12):1215-1221. doi: 10.1016/j.jcin.2017.02.029. Epub 2017 May 31. PubMed PMID: 28579236.
  • Kedhi E, Fabris E, van der Ent M, Kennedy MW, Buszman P, von Birgelen C, Cook S, Wedel H, Zijlstra F. A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial". Am Heart J. 2017 Jun;188:11-17. doi: 10.1016/j.ahj.2017.02.018. Epub 2017 Feb 20. PubMed PMID: 28577666.
  • Arroyo D, Gendre G, Schukraft S, Kallinikou Z, Müller O, Baeriswyl G, Stauffer JC, Goy JJ, Togni M, Cook S, Puricel S. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial. Int J Cardiol. 2017 Sep 15;243:121-125. doi: 10.1016/j.ijcard.2017.05.053. Epub 2017 May 12. PubMed PMID: 28576627.
  • Franzone A, Stortecky S, Räber L, Heg D, Yamaji K, Piccolo R, Asami M, Lanz J, Praz F, Koskinas K, Zanchin T, Wenaweser P, Valgimigli M, Jüni P, Pilgrim T, Windecker S. Effects of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A study of age- and gender-matched cohorts. Int J Cardiol. 2017 Sep 15;243:150-155. doi: 10.1016/j.ijcard.2017.05.071. Epub 2017 May 17. PubMed PMID: 28536005.
  • Rigamonti F, Fahrni G, Maeder M, Cook S, Weilenmann D, Wenaweser P, Röthlisberger C, Corti R, Rickli H, Kaiser C, Roffi M. Switzerland: coronary and structural heart interventions from 2010 to 2015. EuroIntervention. 2017 May 15;13(Z):Z75-Z79. doi: 10.4244/EIJ-D-16-00828. PubMed PMID: 28504236.
  • Bleiziffer S, Bosmans J, Brecker S, Gerckens U, Wenaweser P, Tamburino C, Linke A; ADVANCE Study Investigators. Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study. Clin Res Cardiol. 2017 Oct;106(10):784-795. doi: 10.1007/s00392-017-1120-3. Epub 2017 May 8. Erratum in: Clin Res Cardiol. 2017 Jul 4;:. PubMed PMID: 28484830.
  • Kallinikou Z, Berger A, Ruchat P, Khatchatourov G, Fleisch I, Korkodelovic B, Henchoz E, Marti RA, Cook S, Togni M, Goy JJ. Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes. Arch Cardiovasc Dis. 2017 Jun - Jul;110(6-7):389-394. doi: 10.1016/j.acvd.2016.10.005. Epub 2017 Apr 19. PubMed PMID: 28433509.
  • Franzone A, Pilgrim T, Arnold N, Heg D, Langhammer B, Piccolo R, Roost E, Praz F, Räber L, Valgimigli M, Wenaweser P, Jüni P, Carrel T, Windecker S, Stortecky S. Rates and predictors of hospital readmission after transcatheter aortic valve implantation. Eur Heart J. 2017 Jul 21;38(28):2211-2217. doi: 10.1093/eurheartj/ehx182. PubMed PMID: 28430920.
  • Collet C, Asano T, Miyazaki Y, Tenekecioglu E, Katagiri Y, Sotomi Y, Cavalcante R, de Winter RJ, Kimura T, Gao R, Puricel S, Cook S, Capodanno D,Onuma Y, Serruys PW. Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials. Eur Heart J. 2017 Sep 1;38(33):2559-2566. doi: 10.1093/eurheartj/ehx155.
    PubMed PMID: 28430908.
  • Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R,Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP; SURTAVI Investigators. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017 Apr 6;376(14):1321-1331. doi: 10.1056/NEJMoa1700456. Epub 2017 Mar 17. PubMed PMID: 28304219.
  • Conte G, Caputo ML, Regoli F, Marcon S, Klersy C, Adjibodou B, Del Bufalo A, Moccetti T, Auricchio A. True idiopathic ventricular fibrillation in out-of-hospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long-term follow-up. Europace. 2017 Feb 1;19(2):259-266. doi: 10.1093/europace/euv447. PubMed PMID: 28175278.
  • Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grünenfelder J, Jüni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M. Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. EuroIntervention. 2017 Apr 7;12(18):e2170-e2176. doi: 10.4244/EIJ-D-16-00677. PubMed PMID: 28067197.
  • Jain M, Zellweger M, Wagnières G, van den Bergh H, Cook S, Giraud MN. Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation? Cardiovasc Ther. 2017 Apr;35(2). doi: 10.1111/1755-5922.12238. Review. PubMed PMID: 27893195.
  • Vollenbroich R, Stortecky S, Praz F, Lanz J, Franzone A, Zuk K, Heg D,Valgimigli M, O'Sullivan CJ, Heinisch C, Roost E, Wenaweser P, Windecker S, Pilgrim T. The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation. Am Heart J. 2017 Feb;184:71-80. doi: 10.1016/j.ahj.2016.10.015. Epub 2016 Oct 28. PubMed PMID: 27892889.
  • Vlachojannis GJ, Puricel S, Natsuaki M, Morimoto T, Smits PC, Kimura T. Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials. EuroIntervention. 2017 Mar 20;12(16):1970-1977. doi: 10.4244/EIJ-D-16-00773. PubMed PMID: 27802927.
  • Arroyo D, Bendjelid K, Robert-Ebadi H, Rigamonti F, Siegenthaler N, Giraud R. Suspected Arterial Vasospasm in Femoro-Femoral Venoarterial Extracorporeal Life Support. ASAIO J. 2017 May/Jun;63(3):e35-e38. doi: 10.1097/MAT.0000000000000423. PubMed PMID: 27465096.

Gynécologie-obstétrique

Laboratoire

Médecine interne

Pédiatrie

  • Huber BM, Ogal M, Hasselmann O, von Schoen-Angerer T. Schweizer Interessengruppe für integrative Pädiatrie. Paediatrica 2017;28(3):23-4.
  • Huber BM, Bassler D. Successful treatment of neonatal transitional respiratory disorder with Pulmo/Vivianit comp. in 2 cases. Complement Med Res 2017;24(3):172-4
  • von Schoen-Angerer T, Deckers B, Henes J, Helmert E, Vagedes J. Effect of topical rosemary essential oil in a woman with Raynaud phenomenon and systemic sclerosis. Complementary Therapies in Medicine. In press. https://doi.org/10.1016/j.ctim.2017.10.012
  • von Schoen-Angerer T, Vagedes J, Schneider R, Vlach L, Kleeb S, Huber B, Wildhaber J. Acceptance, satisfaction and cost of an integrative pediatric program for acute respiratory diseases in a Swiss teaching hospital: an implementation report. Complementary Therapies in Medicine. In press. https://doi.org/10.1016/j.ctim.2017.10.005
  • Riley DS, Barber MS, Kienle GS, Aronson JA, Tugwell P, Kiene H, Helfand M, Sox H, G Altman DG, Moher D, G Werthmann PG, von Schoen-Angerer T, Rison R, Koch C, H Sun GH, Hanaway P, Sudak NL, Kaszkin-Bettag M, Shamseer L, Carpenter J, Gagnie JJ. CARE 2013 Explanations and Elaborations: Reporting Guidelines for Case Reports. J Clinical Epidemiology 2017. DOI: 10.1016/j.jclinepi.2017.04.026

Prévention et contrôle de l’infection

  • D. Haefliger, C. Chuard. Légionellose. Rev. Med. Suisse 2017, 13:1732-1736
  • L. Pasquier, C. Chuard. Infections à Listeria monocytogenes. Rev. Med. Suisse 2017, 13:1737-1740
  • D. Genné, C. Chuard. Tropcherinib et Peudeffetzumab vs de nouveaux antibiotiques contre les bactéries résistantes. Rev. Med. Suisse 2017, 13:1723

Radio-Oncologie

  • Pisaturo O, Miéville F, Tercier PA, Allal AS.
    TransitQA - a new method for transit dosimetry of Tomotherapy patients.
    Med Phys. 2017 Nov 14. doi: 10.1002/mp.12672. [Epub ahead of print].
  • Cacheux W, Koessler T, Puppa G, Fernandez E, Ho L, Dietrich PY, Zilli T, Allal AS, Roche B, Ris F, Roth A.
    Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancer.
    Dig Liver Dis. 2017 Nov;49(11):1262-1266. doi: 10.1016/j.dld.2017.08.039. Epub 2017 Sep 5.
  • Lauffer DC, Lang FJW, Küng M, Allal AS.
    Unusual case of laryngeal squamous cell carcinoma with cervical metastasis of a prostatic adenocarcinoma: a case report.
    Case Rep Oncol. 2017 Apr 6;10(1):316-320. eCollection 2017 Jan-Apr.

Page modifiée le 27.09.2018 à 16:47